Skip to main content
. 2021 Oct 21;2021:3809095. doi: 10.1155/2021/3809095

Table 2.

Pairwise comparison of survival for different tumor progression patterns.

Recurrence patterns Whole cohort Head
OS Aps PFS OS Aps PFS
Mst 95%CI P Mst 95%CI P Mst 95%CI P Mst 95%CI P Mst 95%CI P Mst 95%CI P
Local progression Reference 29.37 24.47–39.57 15.93 11.07–25.03 8.97 6.40–10.57 27.60 24.47–37.23 15.93 9.13–21.53 9.13 6.90–10.80
Liver-only metastasis 20.1 17.37–24.63 0.214 12.60 9.83–15.77 0.444 5.03 4.07–6.47 0.014 20.40 17.37–27.90 0.413 12.13 9.83–15.77 0.545 5.47 4.20–6.50 0.050
Lung-only metastasis 17.33 15.33–52.57 0.582 14.70 14.00–30.43 0.581 5.47 2.80–7.47 0.680 17.30 15.33–33.30 0.413 14.70 14.00–17.10 0.443 2.87 2.63–10.60 0.720
Other metastases 23.97 10.77–23.97 0.863 11.23 1.63–29.45 0.154 12.73 9.13–28.70 0.239 16.13 13.55–18.27 0.538 NA NA NA 12.13 10.24–15.27 0.532
Local + distant metastasis 24.87 8.50–34.87 0.247 7.20 3.67–11.57 0.115 5.60 1.73–7.60 0.025 24.11 10.13–30.22 0.094 4.17 2.63–11.57 0.078 6.53 2.10–8.67 0.089
Multiple metastases 17.50 11.20–19.50 0.006 9.20 8.10–12.63 0.023 5.70 3.80–8.30 0.017 17.50 13.80–19.50 0.049 9.20 8.10–12.63 0.121 5.70 2.70–8.63 0.023
Liver-only metastasis Reference 20.1 17.37–24.63 12.60 9.83–15.77 5.03 4.07–6.47 20.40 17.37–27.90 12.13 9.83–15.77 5.47 4.20–6.50
Lung-only metastasis 17.33 15.33–52.57 0.92 14.70 14.00–30.43 0.676 5.47 2.80–7.47 0.285 17.30 15.33–33.30 0.627 14.70 14.00–17.10 0.752 2.87 2.63–10.60 0.496
Other metastases 23.97 10.77–23.97 0.562 11.23 1.63–29.45 0.225 12.73 9.13–28.70 0.036 16.13 13.55–18.27 0.452 NA NA NA 12.13 10.24–15.27 0.250
Local + distant metastasis 24.87 8.50–34.87 0.47 7.20 3.67–11.57 0.286 5.60 1.73–7.60 0.931 24.11 10.13–30.22 0.479 4.17 2.63–11.57 0.171 6.53 2.10–8.67 0.773
Multiple metastases 17.50 11.20–19.50 0.082 9.20 8.10–12.63 0.092 5.70 3.80–8.30 0.076 17.50 13.80–19.50 0.149 9.20 8.10–12.63 0.240 5.70 2.70–8.63 0.855
Lung-only metastasis Reference 17.33 15.33–52.57 14.70 14.00–30.43 5.47 2.80–7.47 17.30 15.33–33.30 14.70 14.00–17.10 2.87 2.63–10.60
Other metastases 23.97 10.77–23.97 0.678 11.23 1.63–29.45 0.125 12.73 9.13–28.70 0.309 16.13 13.55–18.27 0.558 NA NA NA 12.13 10.24–15.27 0.326
Local + distant metastasis 24.87 8.50–34.87 0.491 7.20 3.67–11.57 0.436 5.60 1.73–7.60 0.061 24.11 10.13–30.22 0.553 4.17 2.63–11.57 0.408 6.53 2.10–8.67 0.799
Multiple metastases 17.50 11.20–19.50 0.275 9.20 8.10–12.63 0.022 5.70 3.80–8.30 0.577 17.50 13.80–19.50 0.718 9.20 8.10–12.63 0.025 5.70 2.70–8.63 0.734
Other metastases Reference 23.97 10.77–23.97 11.23 1.63–29.45 12.73 9.13–28.70 16.13 13.55–18.27 NA NA 12.13 10.24–15.27
Local + distant metastasis 24.87 8.50–34.87 0.334 7.20 3.67–11.57 0.686 5.60 1.73–7.60 0.016 24.11 10.13–30.22 0.273 4.17 2.63–11.57 NA 6.53 2.10–8.67 0.223
Multiple metastases 17.50 11.20–19.50 0.108 9.20 8.10–12.63 0.998 5.70 3.80–8.30 0.002 17.50 13.80–19.50 0.617 9.20 8.10–12.63 NA 5.70 2.70–8.63 0.030
Local + distant metastasis Reference 24.87 8.50–34.87 7.20 3.67–11.57 5.60 1.73–7.60 24.11 10.13–30.22 4.17 2.63–11.57 6.53 2.10–8.67
Multiple metastases 17.50 11.20–19.50 0.701 9.20 8.10–12.63 0.958 5.70 3.80–8.30 0.910 17.50 13.80–19.50 0.879 9.20 8.10–12.63 0.770 5.70 2.70–8.63 0.637

NA, not available; other abbreviations as in Table 1.